November 7th, 2017 by aveciapharma
MILFORD, MA – Nitto Avecia, Inc. (Avecia) announced today the successful completion of the first synthesis runs at the 1.6 Mol scale which is believed to be the largest synthesis scale ever executed for oligonucleotide API (active pharmaceutical ingredients) at its new oligonucleotide manufacturing facility...
Read Full Story »
Tags: announcements, testing and development, oligonucleotide
Posted in: Press Release
July 26th, 2017 by aveciapharma
Nitto Denko Avecia Inc. (Avecia) has announced the opening of its new oligonucleotide API (active pharmaceutical ingredients) manufacturing facility in Milford, MA. The opening will commence with a ribbon cutting ceremony in August 2017 onsite at the Milford, MA facility. The ceremony will open with...
Read Full Story »
Tags: announcements, oligonucleotide
Posted in: Company News
May 17th, 2017 by aveciapharma
It's been a busy month so far at Nitto Avecia Pharma Services! We exhibited at two major industry events, both held in San Diego - the 2017 AAPS National Biotechnology Conference and the 2017 TIDES Oligonucleotide and Peptide Therapeutics Annual Meeting. These events gave us the opportunity to meet with...
Read Full Story »
Tags: presentations, industry events, announcements, oligonucleotide
Posted in: Company News
April 25th, 2017 by aveciapharma
We will be attending the AAPS National Biotechnology Conference in San Diego from May 1st to May 3rd. This year's main topics for the conference will be: Bioanalysis & Biomarkers, Biosimilars, Emerging Topics, Formulation Development, Drug Delivery & Manufacturing, and Novel Therapeutic Constructs &...
Read Full Story »
Tags: presentations, industry events, announcements
Posted in: Company News